What is iron for ? Fe 2+ Ferrous iron 2 What is iron for ? Fe 2+ - - PowerPoint PPT Presentation

what is iron for
SMART_READER_LITE
LIVE PREVIEW

What is iron for ? Fe 2+ Ferrous iron 2 What is iron for ? Fe 2+ - - PowerPoint PPT Presentation

2 What is iron for ? Fe 2+ Ferrous iron 2 What is iron for ? Fe 2+ Ferrous iron Heme 2 What is iron for ? Fe 2+ Ferrous iron Heme Oxygen carrier 2 What is iron for ? Fe 2+ Ferrous iron Heme Oxygen carrier Cellular energy production


slide-1
SLIDE 1
slide-2
SLIDE 2
slide-3
SLIDE 3

What is iron for ?

2

Fe2+

Ferrous iron

slide-4
SLIDE 4

What is iron for ?

2

Fe2+

Ferrous iron Heme

slide-5
SLIDE 5

What is iron for ?

2

Fe2+

Oxygen carrier Ferrous iron Heme

slide-6
SLIDE 6

What is iron for ?

2

Fe2+

Oxygen carrier Cellular energy production Ferrous iron Heme

slide-7
SLIDE 7

What is iron for ?

2

Fe2+

Oxygen carrier Cellular energy production Ferrous iron

Iron coli Project Iron related diseases

Heme

slide-8
SLIDE 8

Hemochromatosis

3

slide-9
SLIDE 9

Hemochromatosis

3

2 200 000 cases in Europe

slide-10
SLIDE 10

Hemochromatosis

3

2 200 000 cases in Europe Overabsorption of iron

slide-11
SLIDE 11

Hemochromatosis

3

2 200 000 cases in Europe Overabsorption of iron Permanent insufficiencies and fatigue

slide-12
SLIDE 12

Hemochromatosis

3

2 200 000 cases in Europe Overabsorption of iron Permanent insufficiencies and fatigue Treatment: Blood-letting

slide-13
SLIDE 13

Our strategy

4

slide-14
SLIDE 14

Our strategy

4

slide-15
SLIDE 15

Our strategy

4

Sensing Analyzing Neutralizing

slide-16
SLIDE 16

Our strategy

4

slide-17
SLIDE 17

Our strategy

4

slide-18
SLIDE 18

Our strategy

4

slide-19
SLIDE 19

Our strategy

4

slide-20
SLIDE 20

Our strategy

4

slide-21
SLIDE 21

Our goal

Alternative treatment to blood-lettings

6

Chelating the iron in the intestine

Sensor Inverter Chelator

slide-22
SLIDE 22

Enterobactins to chelate them all

7

Ka = 1039 M−1 Enterobactin structure Natural production when [Fe2+] < 10-7 M

slide-23
SLIDE 23

Human Practice

8

slide-24
SLIDE 24

Patients response to Iron Coli treatment

9

Would you take our treatment if it was allowed by the national agency for drug safety ?

slide-25
SLIDE 25

Patients response to Iron Coli treatment

9

« Would you take our treatment if it was allowed by the national agency for drug safety ? »

N = 270 answers

slide-26
SLIDE 26

Potential consequences of Iron Coli

10

Fault Tree

slide-27
SLIDE 27

Potential consequences of Iron Coli

10

Fault Tree

slide-28
SLIDE 28

Model

11

slide-29
SLIDE 29

Is Flush strategy viable ?

12

Can Iron coli prevent iron absorption ?

slide-30
SLIDE 30

Is Flush strategy viable ?

12

Can Iron coli prevent iron absorption ?

slide-31
SLIDE 31

Is Flush strategy viable ?

12

Can Iron coli prevent iron absorption ?

ODE Model Assumption: Instantaneous enterobactin production

slide-32
SLIDE 32

Exploring flush strategy

13

Iron absorption Iron in duodenum

Without treatment Without treatment

slide-33
SLIDE 33

Exploring flush strategy

13

Iron absorption Iron in duodenum

Without treatment With treatment Without treatment With treatment

slide-34
SLIDE 34

Exploring flush strategy

13

42 sec. flush: Iron absorption is divided by 2

Iron absorption Iron in duodenum

Without treatment With treatment Without treatment With treatment

slide-35
SLIDE 35

Less frequent blood-lettings beneficial to working patients

14

Would you take our treatment if it’s allowed by the national agency for drug safety ?

N = 270 answers

slide-36
SLIDE 36

Less frequent blood-lettings beneficial to working patients

14

Would you take our treatment if it’s allowed by the national agency for drug safety ?

N = 270 answers

Bloodletting is very time-consuming

slide-37
SLIDE 37

Biology

15

slide-38
SLIDE 38

Project overview

16

Sensor Inverter Chelator Iron coli

slide-39
SLIDE 39

Harnessing FUR for iron sensing

Sensor system

17

Extracted promoters:

  • pAceB
  • pFepA
  • pFes
  • pYncE
slide-40
SLIDE 40

Harnessing FUR for iron sensing

Sensor system

17

Extracted promoters:

GFP pAceB T RBS FUR Fe2+

Absence of iron

  • pFes
  • pYncE
  • pAceB
  • pFepA
slide-41
SLIDE 41

Harnessing FUR for iron sensing

Sensor system

17

Extracted promoters:

GFP pAceB T RBS FUR Fe2+

Absence of iron

GFP pAceB T RBS FUR Fe2+

Presence of iron

  • pFes
  • pYncE
  • pAceB
  • pFepA
slide-42
SLIDE 42

Characterisation of iron sensing device

18

Cultures in varying iron concentration No significant reduction of growth rate

(h)

slide-43
SLIDE 43

Characterisation of iron sensing device

18

Cultures in varying iron concentration No significant reduction of growth rate repressed by iron

(h)

BBa_K1163102 W

slide-44
SLIDE 44

Inverting the signal

19

 Activation

FUR

𝐆𝐟𝟑+ LacI T RBS T RBS RFP

Presence of iron

slide-45
SLIDE 45

Inverting the signal

19

 Activation

FUR

𝐆𝐟𝟑+ LacI T RBS T RBS RFP

Presence of iron

FUR

LacI T RBS

No Activation

LacI

T RBS RFP

Absence of iron

slide-46
SLIDE 46

Characterisation of iron sensing device

20

Cultures in varying iron concentration No significant reduction of growth rate

(h)

RFP/D.O.

slide-47
SLIDE 47

Characterisation of iron sensing device

20

Cultures in varying iron concentration No significant reduction of growth rate inverter and reporter – the system expresses RFP as a function of iron concentration K1163103

(h)

J04450

RFP/D.O.

slide-48
SLIDE 48

Enterobactin biosynthesis pathway

21

6 enzymes: EntA, EntB, EntC, EntD, EntE, EntF

slide-49
SLIDE 49

Genome scale metabolic model

Can our construct unbalance E. coli metabolism?

22

slide-50
SLIDE 50

Genome scale metabolic model

Can our construct unbalance E. coli metabolism?

22

slide-51
SLIDE 51

Genome scale metabolic model

Can our construct unbalance E. coli metabolism?

22

slide-52
SLIDE 52

Genome scale metabolic model

Can our construct unbalance E. coli metabolism?

22

  • E. Coli iJR904 + 1 reaction (ENTSYNTH)

Flux Balance Analysis framework

slide-53
SLIDE 53

FBA simulations

23

Need to add chorismate to the medium

slide-54
SLIDE 54

The chelating device

Design 1: Fully refactored enterobactin operon

24

Design 2: Semi-refactored operon

EntB EntC EntE pLac EntA EntD EntF pLac

Amp Kan

EntC EntE EntB pLac EntA EntD EntF EntH

Tet

All individual parts are ready

slide-55
SLIDE 55

Enterobactin production kinetics

25

How much time from Iron Sensing to enterobactin production?

slide-56
SLIDE 56

Enterobactin production kinetics

25

How much time from Iron Sensing to enterobactin production?

slide-57
SLIDE 57

Enterobactin production kinetics

25

How much time from Iron Sensing to enterobactin production?

slide-58
SLIDE 58

Enterobactin production kinetics

25

How much time from Iron Sensing to enterobactin production?

ODE Model Inverter system + Chemical kinetics Parameters → literature

slide-59
SLIDE 59

Interpretation of simulations

26

slide-60
SLIDE 60

Interpretation of simulations

26

Iron Enzymes Enterobactin Time (min)

slide-61
SLIDE 61

Interpretation of simulations

26

Enterobactin production after 5 hours

Iron Enzymes Enterobactin Time (min)

slide-62
SLIDE 62

Interpretation of simulations

26

Enterobactin production after 5 hours

Need to rethink flush approach

Iron Enzymes Enterobactin Time (min)

slide-63
SLIDE 63

Capsule

27

slide-64
SLIDE 64

Iron coli needs time to act

28

How to give Iron coli enough time to produce enterobactins ?

slide-65
SLIDE 65

Iron coli needs time to act

28

How to give Iron coli enough time to produce enterobactins ?

Stomach Upper intestine

slide-66
SLIDE 66

Improving galenic formulation for bacteria

29

slide-67
SLIDE 67

Improving galenic formulation for bacteria

29

slide-68
SLIDE 68

Slowed down flush strategy

Viscous matrix retains Iron coli in the upper intestine

30

HPMC matrix Intestinal barrier

slide-69
SLIDE 69

Capsule manufacturing

31

slide-70
SLIDE 70

Capsule manufacturing

31

slide-71
SLIDE 71

Capsule manufacturing

31

slide-72
SLIDE 72

Capsule follows the actual norms

32

Requirements of European Pharmacopeoa for a gastro-enteric resistant capsule

slide-73
SLIDE 73

Capsule follows the actual norms

32

Requirements of European Pharmacopeoa for a gastro-enteric resistant capsule

pH = 2 (Stomach)

No dissolution after 2 hours

slide-74
SLIDE 74

Capsule follows the actual norms

32

Requirements of European Pharmacopeoa for a gastro-enteric resistant capsule

pH = 7 (Upper intestine)

Dissolution before 1 hour

pH = 2 (Stomach)

No dissolution after 2 hours

slide-75
SLIDE 75

Gathering patients, experts and the team

33

We organised a seminar with researchers, clinicians, associations of patients, patients, and our iGEM Evry Team

slide-76
SLIDE 76

Confronting our project to reality

34

What we want/need to do How we achieve it Result

slide-77
SLIDE 77

Confronting our project to reality

34

What we want/need to do How we achieve it Result Ideal situation

slide-78
SLIDE 78

Confronting our project to reality

34

Human goal

Helping hemochromatosis patients

What we want/need to do How we achieve it Result Ideal situation

slide-79
SLIDE 79

Confronting our project to reality

34

Human goal

Helping hemochromatosis patients

Means

Synthetic biology

What we want/need to do How we achieve it Result Ideal situation

slide-80
SLIDE 80

Confronting our project to reality

34

Human goal

Helping hemochromatosis patients

Means

Synthetic biology

Project

Iron coli

What we want/need to do How we achieve it Result Ideal situation

slide-81
SLIDE 81

Confronting our project to reality

34

Concrete iGEM situation What we want/need to do How we achieve it Result

slide-82
SLIDE 82

Confronting our project to reality

34

Concrete iGEM situation What we want/need to do How we achieve it Result

Means

Synthetic biology

slide-83
SLIDE 83

Confronting our project to reality

34

Concrete iGEM situation What we want/need to do How we achieve it Result

Means

Synthetic biology

Project

Iron coli

slide-84
SLIDE 84

Confronting our project to reality

34

Concrete iGEM situation What we want/need to do How we achieve it Result

Means

Synthetic biology

Project

Iron coli

Human goal

Helping hemochromatosis patients

slide-85
SLIDE 85

Philosophical issue

35

We want to apply synthetic biology to reduce the suffering of hematochromatosis patients Are we using patients to prove the usefulness of synthetic biology ?

slide-86
SLIDE 86

Achievements

36

We built and characterised 8 biobricks

  • Several iron sensing systems
  • A working signal inverter

K1163102 K1163103

slide-87
SLIDE 87

Achievements

36

We built and characterised 8 biobricks

  • Several iron sensing systems
  • A working signal inverter

K1163102 K1163103

We created an original delivery capsule

slide-88
SLIDE 88

Achievements

36

We built and characterised 8 biobricks

  • Several iron sensing systems
  • A working signal inverter

K1163102 K1163103

We created an original delivery capsule Modelling helped many steps of the design

  • ODE model for disease and the treatment in the gut
  • Kinetic equations model of enterobactin synthesis
  • FBA model for determining metabolism interactions
slide-89
SLIDE 89

Achievements

36

We built and characterised 8 biobricks

  • Several iron sensing systems
  • A working signal inverter

K1163102 K1163103

We made an integrated human practice study

  • Patient survey and opinion
  • Seminar Doctor/Patient/Researcher
  • Constructed a fault tree
  • Philosophical study on goals and means in SynBio

We created an original delivery capsule Modelling helped many steps of the design

  • ODE model for disease and the treatment in the gut
  • Kinetic equations model of enterobactin synthesis
  • FBA model for determining metabolism interactions
slide-90
SLIDE 90

Coming soon

Finalise cloning of enterobactin genes

37

slide-91
SLIDE 91

Coming soon

Future characterisation (Brian C. Louden et al., 2011)

Finalise cloning of enterobactin genes Characterise their production

37

slide-92
SLIDE 92

Sponsors

38